dopamine receptors — Drug Target

All drugs that target dopamine receptors — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Nonergot Dopamine Agonist [EPC] · Dopamine agonist

Marketed (1)

• Neupro · UCB · Nonergot Dopamine Agonist [EPC] · Neuroscience
  Rotigotine stimulates dopamine receptors in the brain, which may help treat Parkinson's disease and Restless Legs Syndrome.

Phase 3 pipeline (1)

• Placebo- Sinemet · Intec Pharma Ltd. · Dopamine agonist · Neurology
  Sinemet is a combination of carbidopa and levodopa, which work together to increase dopamine levels in the brain.